| John Stephen Mitchell, | |
|
1500 Forest Glen Rd, Silver Spring, MD 20910-1483 | |
| (301) 754-7335 | |
| Not Available |
| Full Name | John Stephen Mitchell |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 1500 Forest Glen Rd, Silver Spring, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104938315 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | D46552 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Stephen Mitchell, Po Box 2070, Germantown, MD 20875-2070 Ph: () - | John Stephen Mitchell, 1500 Forest Glen Rd, Silver Spring, MD 20910-1483 Ph: (301) 754-7335 |
News Archive
Among patients with deadly cancers, more than 90 percent die because of metastatic spread of their disease. Looking to target a key pathway in order to interfere with the processes that lead to tumor spread, a research team led by Irwin H. Gelman, Ph.D., of Roswell Park Cancer Institute (RPCI) has identified a new suppressor of cancer metastasis that may point the way toward development of more effective treatments for prostate cancers and other malignant solid tumors.
Trophos today announces that top-line results from a pivotal clinical trial of its lead product candidate olesoxime in spinal muscular atrophy (SMA) show a beneficial effect on the maintenance of motor function in SMA patients. If approved, olesoxime could be the first treatment specifically developed for SMA patients.
In the past year, drug makers' thirst for innovation combined with small companies' dwindling operating capital to drive merger and acquisition activity. At the high end of the scale, consolidation among industry leaders created some of the richest pharmaceutical mergers in history.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
Identifying risk factors in hospital readmissions could help improve patient care and hospital bottom lines, according to a study recently completed by Georgia State University's Experimental Economics Center and a team from the Emory University School of Medicine.
› Verified 8 days ago
Dr. Maria-magdalena Tomaszewski, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 8403 Colesville Rd Ste 1600, Silver Spring, MD 20910 Phone: 240-485-5100 Fax: 240-485-5102 | |
Dr. Theresa T. Sherrod, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 8561 Fenton St, Suite 250, Silver Spring, MD 20910 Phone: 240-821-1222 Fax: 240-821-1227 | |
Ana Szarfman, Pathology Medicare: Not Enrolled in Medicare Practice Location: 10903 New Hampshire Ave # 22/4187, Silver Spring, MD 20993 Phone: 202-247-8573 | |
Dr. Bose Kalampanayil, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 15315 Holly Grove Rd, Silver Spring, MD 20905 Phone: 800-270-1862 | |
Dr. Yang Zhang, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 606 Stephen Sitter Ave, Silver Spring, MD 20910 Phone: 301-295-5640 | |
Dr. Prakash Jha, MD, MPH Pathology Medicare: Not Enrolled in Medicare Practice Location: 8403 Colesville Road, Suite 1600, Silver Spring, MD 20910 Phone: 202-270-9430 Fax: 804-836-1395 |